US healthcare CDMO market is projected to grow at a significant CAGR during the forecast period (2020-2026). The outsourcing services is one of the fastest-growing markets within the pharmaceutical and biotechnology industries and the contract manufacturing segment represents a significant portion of the outsourcing market. There has been a significant shift in the way companies are looking to outsource and this differs significantly across tiers and types of companies.
Browse the full report description US Healthcare Contract Development And Manufacturing Organization (CDMO) Market Size, Share & Trends Analysis Report by Services (Contract Development and Contract Manufacturing) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/us-healthcare-cdmo-market
Pharmaceutical contract manufacturing in the US is fueled by an increase in biotechnology companies. These companies are dedicated to developing drug compounds for specific therapeutic areas. However, these companies lack infrastructure in the areas of formulation, clinical and regulatory agency submission.
With the biotechnology and pharmaceutical industries striving for cost minimization and profit maximization, outsourcing production has become an ever-increasing trend as these are striving for cost minimization and profit maximization. The US is one of the largest pharmaceutical industries, is dependent on other countries for products such as the countries in the Asia-Pacific region. A shift has been observed to outsource manufacturing capabilities to CDMOs in the Asia-Pacific region, specifically in India. Cost benefits owing to low labor costs and capital expenditures are the key reasons for outsourcing to the Asia-Pacific region. Hence, the CDMOs, by providing low-services and without compromising with the quality, may create ample opportunity for the growth of the market in the near future.
Market Coverage
Report Elements | Details |
Study Period | 2019-2026 |
Base year | 2019 |
Forecast period | 2020-2026 |
Segments Covered | By Services |
Key Companies Profiled | AbbVie Inc., Baxter International, Inc., Catalent, Inc., Pfizer Inc., Thermo Fisher Scientific Inc., Jabil Inc., and others |
Key Questions Addressed by the Report
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
o Recommendations
US healthcare CDMO Market – Segmentation
By Services
o Clinical
o Preclinical
o Laboratory Services
o Active Pharmaceutical Ingredients( API)
o Finish Dosage Formulations
o Medical Devices
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/us-healthcare-cdmo-market